|
1
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen SL and Morgan TR: The natural history
of hepatitis C virus (HCV) infection. Int J Med Sci. 3:47–52. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshizawa H: Hepatocellular carcinoma
associated with hepatitis C virus infection in Japan: Projection to
other countries in the foreseeable future. Oncology. 62(Suppl 1):
8–17. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colombo M and Iavarone M: Role of
antiviral treatment for HCC prevention. Best Pract Res Clin
Gastroenterol. 28:771–781. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alavian SM and Haghbin H: Relative
importance of hepatitis B and C viruses in hepatocellular carcinoma
in EMRO countries and the Middle East: A systematic review. Hepat
Mon. 16:e351062016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang L, Marcell L and Kottilil S: Systemic
manifestations of hepatitis C infection. Infect Agent Cancer.
11:292016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kato N, Ji G, Wang Y, Baba M, Hoshida Y,
Otsuka M, Taniguchi H, Moriyama M, Dharel N, Goto T, et al:
Large-scale search of single nucleotide polymorphisms for
hepatocellular carcinoma susceptibility genes in patients with
hepatitis C. Hepatology. 42:846–853. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gu X, Qi P, Zhou F, Ji Q, Wang H, Dou T,
Zhao Y and Gao C: An intronic polymorphism in the
corticotropin-releasing hormone receptor 2 gene increases
susceptibility to HBV-related hepatocellular carcinoma in Chinese
population. Hum Genet. 127:75–81. 2010. View Article : Google Scholar
|
|
9
|
Segat L, Milanese M, Pirulli D, Trevisiol
C, Lupo F, Salizzoni M, Amoroso A and Crovella S: Secreted protein
acidic and rich in cysteine (SPARC) gene polymorphism association
with hepatocellular carcinoma in Italian patients. J Gastroenterol
Hepatol. 24:1840–1846. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang KS, Lee CM, Teng HC, Huang MJ and
Huang CS: UDP-glucuronosyltransferase 1A7 polymorphisms are
associated with liver cirrhosis. Biochem Biophys Res Commun.
366:643–648. 2008. View Article : Google Scholar
|
|
11
|
Kim YS, Cheong JY, Cho SW, Lee KM, Hwang
JC, Oh B, Kim K, Lee JA, Park BL, Cheong HS, et al: A functional
SNP of the Interleukin-18 gene is associated with the presence of
hepatocellular carcinoma in hepatitis B virus-infected patients.
Dig Dis Sci. 54:2722–2728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tanaka Y, Nishida N, Sugiyama M, Kurosaki
M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S,
et al: Genome-wide association of IL28B with response to pegylated
interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat
Genet. 41:1105–1109. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nalpas B, Lavialle-Meziani R, Plancoulaine
S, Jouanguy E, Nalpas A, Munteanu M, Charlotte F, Ranque B, Patin
E, Heath S, et al: Interferon gamma receptor 2 gene variants are
associated with liver fibrosis in patients with chronic hepatitis C
infection. Gut. 59:1120–1126. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tillmann HL, Thompson AJ, Patel K, Wiese
M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U,
Capka E, et al: German Anti-D Study Group: A polymorphism near
IL28B is associated with spontaneous clearance of acute hepatitis C
virus and jaundice. Gastroenterology. 139:1586–1592. 1592.e12010.
View Article : Google Scholar
|
|
15
|
GBD 2015 Disease and Injury Incidence and
Prevalence Collaborators: Global, regional, and national incidence,
prevalence and years lived with disability for 310 disease and
injuries, 1990–2015: a systematic analysis for the Global Burden of
Disease Study 2015. Lancet. 388:1545–1602. 2016. View Article : Google Scholar
|
|
16
|
Clendenen TV, Rendleman J, Ge W, Koenig
KL, Wirgin I, Currie D, Shore RE, Kirchhoff T and
Zeleniuch-Jacquotte A: Genotyping of single nucleotide
polymorphisms in DNA isolated from serum using sequenom MassARRAY
technology. PLoS One. 10:e01359432015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirakawa M, Tanaka T, Hashimoto Y, Kuroda
M, Takagi T and Nakamura Y: JSNP: A database of common gene
variations in the Japanese population. Nucleic Acids Res.
30:158–162. 2002. View Article : Google Scholar :
|
|
18
|
Haga H, Yamada R, Ohnishi Y, Nakamura Y
and Tanaka T: Gene-based SNP discovery as part of the Japanese
Millennium Genome Project: Identification of 190,562 genetic
variations in the human genome Single-nucleotide polymorphism. J
Hum Genet. 47:605–610. 2002. View Article : Google Scholar
|
|
19
|
Sherry ST, Ward MH, Kholodov M, Baker J,
Phan L, Smigielski EM and Sirotkin K: dbSNP: The NCBI database of
genetic variation. Nucleic Acids Res. 29:308–311. 2001. View Article : Google Scholar :
|
|
20
|
Kuriyama S, Yaegashi N, Nagami F, Arai T,
Kawaguchi Y, Osumi N, Sakaida M, Suzuki Y, Nakayama K, Hashizume H,
et al: The Tohoku Medical Megabank Project: Design and Mission. J
Epidemiol. 26:493–511. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yue P, Melamud E and Moult J: SNPs3D:
Candidate gene and SNP selection for association studies. BMC
Bioinformatics. 7:1662006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakamura Y: The BioBank Japan Project.
Clin Adv Hematol Oncol. 5:696–697. 2007.PubMed/NCBI
|
|
23
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grantham R: Amino acid difference formula
to help explain protein evolution. Science. 185:862–864. 1974.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Machiela MJ and Chanock SJ: LDlink: A
web-based application for exploring population-specific haplotype
structure and linking correlated alleles of possible functional
variants. Bioinformatics. 31:3555–3557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Auton A, Brooks LD, Durbin RM, Garrison
EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA and
Abecasis GR; 1000 Genomes Project Consortium: A global reference
for human genetic variation. Nature. 526:68–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Levin AM, Zuhlke KA, Ray AM, Cooney KA and
Douglas JA: Sequence variation in alpha-methylacyl-CoA racemase and
risk of early-onset and familial prostate cancer. Prostate.
67:1507–1513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Daugherty SE, Platz EA, Shugart YY, Fallin
MD, Isaacs WB, Chatterjee N, Welch R, Huang WY and Hayes RB:
Variants in the alpha-Methylacyl-CoA racemase gene and the
association with advanced distal colorectal adenoma. Cancer
Epidemiol Biomarkers Prev. 16:1536–1542. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
FitzGerald LM, Thomson R, Polanowski A,
Patterson B, McKay JD, Stankovich J and Dickinson JL: Sequence
variants of alpha-methylacyl-CoA racemase are associated with
prostate cancer risk: A replication study in an ethnically
homogeneous population. Prostate. 68:1373–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pruthi RS, Derksen E and Gaston K:
Cyclooxygenase-2 as a potential target in the prevention and
treatment of genitourinary tumors: A review. J Urol. 169:2352–2359.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ng IO, Liang ZD, Cao L and Lee TK: DLC-1
is deleted in primary hepatocellular carcinoma and exerts
inhibitory effects on the proliferation of hepatoma cell lines with
deleted DLC-1. Cancer Res. 60:6581–6584. 2000.PubMed/NCBI
|
|
32
|
Trebicka J and Schierwagen R: Statins, Rho
GTPases and KLF2: New mechanistic insight into liver fibrosis and
portal hypertension. Gut. 64:1349–1350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Khan FS, Ali I, Afridi UK, Ishtiaq M and
Mehmood R: Epigenetic mechanisms regulating the development of
hepatocellular carcinoma and their promise for therapeutics.
Hepatol Int. 11:45–53. 2017. View Article : Google Scholar
|
|
34
|
Haiman CA, Hsu C, de Bakker PI, Frasco M,
Sheng X, Van Den Berg D, Casagrande JT, Kolonel LN, Le Marchand L,
Hankinson SE, et al: Comprehensive association testing of common
genetic variation in DNA repair pathway genes in relationship with
breast cancer risk in multiple populations. Hum Mol Genet.
17:825–834. 2008. View Article : Google Scholar
|
|
35
|
de Boer J and Hoeijmakers JH: Nucleotide
excision repair and human syndromes. Carcinogenesis. 21:453–460.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krupa R, Sliwinski T, Morawiec Z,
Pawlowska E, Zadrozny M and Blasiak J: Association between
polymorphisms of the BRCA2 gene and clinical parameters in breast
cancer. Exp Oncol. 31:250–251. 2009.PubMed/NCBI
|
|
37
|
Carreira A, Hilario J, Amitani I, Baskin
RJ, Shivji MK, Venkitaraman AR and Kowalczykowski SC: The BRC
repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.
Cell. 136:1032–1043. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Johnson N, Fletcher O, Palles C, Rudd M,
Webb E, Sellick G, dos Santos Silva I, McCormack V, Gibson L,
Fraser A, et al: Counting potentially functional variants in BRCA1,
BRCA2 and ATM predicts breast cancer susceptibility. Hum Mol Genet.
16:1051–1057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ishitobi M, Miyoshi Y, Ando A, Hasegawa S,
Egawa C, Tamaki Y, Monden M and Noguchi S: Association of BRCA2
polymorphism at codon 784 (Met/Val) with breast cancer risk and
prognosis. Clin Cancer Res. 9:1376–1380. 2003.PubMed/NCBI
|
|
40
|
Sliwinski T, Krupa R, Majsterek I, Rykala
J, Kolacinska A, Morawiec Z, Drzewoski J, Zadrozny M and Blasiak J:
Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast
Cancer Res Treat. 94:105–109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peltomäki P: Deficient DNA mismatch
repair: A common etiologic factor for colon cancer. Hum Mol Genet.
10:735–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yuan ZQ, Gottlieb B, Beitel LK, Wong N,
Gordon PH, Wang Q, Puisieux A, Foulkes WD and Trifiro M:
Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished
by single nucleotide polymorphisms. Hum Mutat. 19:108–113. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Umar A, Boland CR, Terdiman JP, Syngal S,
de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ,
Hamelin R, et al: Revised Bethesda Guidelines for hereditary
nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite
instability. J Natl Cancer Inst. 96:261–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cal S, Obaya AJ, Llamazares M, Garabaya C,
Quesada V and López-Otín C: Cloning, expression analysis, and
structural characterization of seven novel human ADAMTSs, a family
of metalloproteinases with disintegrin and thrombospondin-1
domains. Gene. 283:49–62. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vázquez F, Hastings G, Ortega MA, Lane TF,
Oikemus S, Lombardo M and Iruela-Arispe ML: METH-1, a human
ortholog of ADAMTS-1, and METH-2 are members of a new family of
proteins with angio-inhibitory activity. J Biol Chem.
274:23349–23357. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Colige A, Sieron AL, Li SW, Schwarze U,
Petty E, Wertelecki W, Wilcox W, Krakow D, Cohn DH, Reardon W, et
al: Human Ehlers-Danlos syndrome type VII C and bovine
dermatosparaxis are caused by mutations in the procollagen I
N-proteinase gene. Am J Hum Genet. 65:308–317. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Rodriguez-Lopez J, Pombo-Suarez M,
Loughlin J, Tsezou A, Blanco FJ, Meulenbelt I, Slagboom PE, Valdes
AM, Spector TD, Gomez-Reino JJ, et al: Association of an sSNP in
ADAMTS14 to some osteoarthritis phenotypes. Osteoarthritis
Cartilage. 17:321–327. 2009. View Article : Google Scholar
|
|
48
|
Hu X, Chen H, Jin M, Wang X, Lee J, Xu W,
Zhang R, Li S and Niu J: Molecular cytogenetic characterization of
undifferentiated embryonal sarcoma of the liver: A case report and
literature review. Mol Cytogenet. 5:262012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kumar S, Rao N and Ge R: Emerging Roles of
ADAMTSs in Angiogenesis and Cancer. Cancers (Basel). 4:1252–1299.
2012. View Article : Google Scholar
|
|
50
|
Bonnans C, Chou J and Werb Z: Remodelling
the extracellular matrix in development and disease. Nat Rev Mol
Cell Biol. 15:786–801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Goldman O, Han S, Sourisseau M, Dziedzic
N, Hamou W, Corneo B, D'Souza S, Sato T, Kotton DN, Bissig KD, et
al: KDR identifies a conserved human and murine hepatic progenitor
and instructs early liver development. Cell Stem Cell. 12:748–760.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Basu P, Chandna P, Bamezai RNK, Siddiqi M,
Saranath D, Lear A and Ratnam S: MassARRAY spectrometry is more
sensitive than PreTect HPV-Proofer and consensus PCR for
type-specific detection of high-risk oncogenic human papillomavirus
genotypes in cervical cancer. J Clin Microbiol. 49:3537–3544. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kim MJ, Lee EJ, Chun SM, Jang SJ, Kim DS,
Lee DH and Youk EG: The significance of ectopic crypt formation in
the differential diagnosis of colorectal polyps. Diagn Pathol.
9:2122014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Matsuura K, Sawai H, Ikeo K, Ogawa S, Iio
E, Isogawa M, Shimada N, Komori A, Toyoda H, Kumada T, et al
Japanese Genome-Wide Association Study Group for Viral Hepatitis:
Genome-wide association study identifies TLL1 variant associated
with development of hepatocellular carcinoma after eradication of
hepatitis C virus infection. Gastroenterology. 152:1383–1394. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Peters MG and Terrault NA: Alcohol use and
hepatitis C. Hepatology. 36(Suppl 1): S220–S225. 2002.PubMed/NCBI
|
|
56
|
Aleksandrova K, Stelmach-Mardas M and
Schlesinger S: Obesity and liver cancer. Recent Results Cancer Res.
208:177–198. 2016. View Article : Google Scholar : PubMed/NCBI
|
